Lorazepam Sedation for Critically Ill Children

Clinical trial NCT00109395 · COMPLETED

Trial details

NCT number: NCT00109395
Sponsor: The Emmes Company, LLC
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Critical Illness

Start date: 2004-09-01
Primary completion: 2007-09-01
Enrollment: 179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.